Cargando…

Brilacidin Demonstrates Inhibition of SARS-CoV-2 in Cell Culture

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the newly emergent causative agent of coronavirus disease-19 (COVID-19), has resulted in more than two million deaths worldwide since it was first detected in 2019. There is a critical global need for therapeutic intervention strategies t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bakovic, Allison, Risner, Kenneth, Bhalla, Nishank, Alem, Farhang, Chang, Theresa L., Weston, Warren K., Harness, Jane A., Narayanan, Aarthi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7916214/ https://www.ncbi.nlm.nih.gov/pubmed/33572467 http://dx.doi.org/10.3390/v13020271

Ejemplares similares

Maraviroc inhibits SARS-CoV-2 multiplication and s-protein mediated cell fusion in cell culture
por: Risner, Kenneth H., et al.
Publicado: (2022)

Inhibitors of Venezuelan Equine Encephalitis Virus Identified Based on Host Interaction Partners of Viral Non-Structural Protein 3
por: Bakovic, Allison, et al.
Publicado: (2021)

Efficacy of FDA-Approved Anti-Inflammatory Drugs Against Venezuelan Equine Encephalitis Virus Infection
por: Risner, Kenneth, et al.
Publicado: (2019)

Venezuelan Equine Encephalitis Virus nsP3 Phosphorylation Can Be Mediated by IKKβ Kinase Activity and Abrogation of Phosphorylation Inhibits Negative-Strand Synthesis
por: Bakovic, Allison, et al.
Publicado: (2020)

Synthetic Host Defense Peptides Inhibit Venezuelan Equine Encephalitis Virus Replication and the Associated Inflammatory Response
por: Ahmed, Aslaa, et al.
Publicado: (2020)

Inhibition of Venezuelan Equine Encephalitis Virus Using Small Interfering RNAs
por: Haikerwal, Amrita, et al.
Publicado: (2022)

Inhibitors of the Ubiquitin-Mediated Signaling Pathway Exhibit Broad-Spectrum Antiviral Activities against New World Alphaviruses
por: Boghdeh, Niloufar A., et al.
Publicado: (2023)

Application of a Human Blood Brain Barrier Organ-on-a-Chip Model to Evaluate Small Molecule Effectiveness against Venezuelan Equine Encephalitis Virus
por: Boghdeh, Niloufar A., et al.
Publicado: (2022)

DNA origami presenting the receptor binding domain of SARS-CoV-2 elicit robust protective immune response
por: Oktay, Esra, et al.
Publicado: (2023)

Human Antimicrobial Peptides as Therapeutics for Viral Infections
por: Ahmed, Aslaa, et al.
Publicado: (2019)

A host defense peptide mimetic, brilacidin, potentiates caspofungin antifungal activity against human pathogenic fungi
por: dos Reis, Thaila Fernanda, et al.
Publicado: (2023)

Mitochondrial-Directed Antioxidant Reduces Microglial-Induced Inflammation in Murine In Vitro Model of TC-83 Infection
por: Keck, Forrest, et al.
Publicado: (2018)

Interactions of Equine Viruses with the Host Kinase Machinery and Implications for One Health and Human Disease
por: Anderson, Carol, et al.
Publicado: (2023)

Brilacidin, a COVID‐19 drug candidate, demonstrates broad‐spectrum antiviral activity against human coronaviruses OC43, 229E, and NL63 through targeting both the virus and the host cell
por: Hu, Yanmei, et al.
Publicado: (2022)

Direct and indirect pro-inflammatory cytokine response resulting from TC-83 infection of glial cells
por: Keck, Forrest, et al.
Publicado: (2018)

Proteomic Discovery of VEEV E2-Host Partner Interactions Identifies GRP78 Inhibitor HA15 as a Potential Therapeutic for Alphavirus Infections
por: Barrera, Michael D., et al.
Publicado: (2021)

Development of a hybrid alphavirus-SARS-CoV-2 pseudovirion for rapid quantification of neutralization antibodies and antiviral drugs
por: Hetrick, Brian, et al.
Publicado: (2022)

Numb-associated kinases are required for SARS-CoV-2 infection and are cellular targets for antiviral strategies
por: Karim, Marwah, et al.
Publicado: (2022)

The transcriptional landscape of Venezuelan equine encephalitis virus (TC-83) infection
por: Yao, Zhiyuan, et al.
Publicado: (2021)

Hyperimmunized Chickens Produce Neutralizing Antibodies against SARS-CoV-2
por: Aston, Emily J., et al.
Publicado: (2022)

77.5 Social Media Contagion in the Context of the COVID-19 Pandemic
por: Harness, Jane
Publicado: (2022)

Durability of Viral Neutralization in Asymptomatic Coronavirus Disease 2019 for at Least 60 Days
por: Haymond, Amanda, et al.
Publicado: (2021)

Organoids demonstrate gut infection by SARS-CoV-2
por: Dickson, Iain
Publicado: (2020)

Development and characterization of two equine formulations towards SARS-CoV-2 proteins for the potential treatment of COVID-19
por: León, Guillermo, et al.
Publicado: (2021)

The Slowing Rate of CpG Depletion in SARS-CoV-2 Genomes Is Consistent with Adaptations to the Human Host
por: Kumar, Akhil, et al.
Publicado: (2022)

The C-Terminal Portion of the Nucleocapsid Protein Demonstrates SARS-CoV Antigenicity
por: Liu, Guozhen, et al.
Publicado: (2003)

Combination of antiviral drugs inhibits SARS-CoV-2 polymerase and exonuclease and demonstrates COVID-19 therapeutic potential in viral cell culture
por: Wang, Xuanting, et al.
Publicado: (2022)

Insect cell expression and purification of recombinant SARS‐COV‐2 spike proteins that demonstrate ACE2 binding
por: Struble, Lucas R., et al.
Publicado: (2022)

Observations by Dr J. Harness, on the Use of the Gastric Fluid of Graminivorous Animals in the Cure of Ulcers
por: Harness, J.
Publicado: (1797)

Temporal Dynamics and Evolution of SARS-CoV-2 Demonstrate the Necessity of Ongoing Viral Genome Sequencing in Ontario, Canada
por: Sjaarda, Calvin P., et al.
Publicado: (2021)

A SARS-CoV-2 Infection Model in Mice Demonstrates Protection by Neutralizing Antibodies
por: Hassan, Ahmed O., et al.
Publicado: (2020)

SARS-COV-2-INDUCED COAGULOPATHY DEMONSTRATING HEMORRHAGIC CARDIAC TAMPONADE: A TIGHT SQUEEZE
por: KISSAU, DANIEL, et al.
Publicado: (2022)

In Vitro Selection of Remdesivir-Resistant SARS-CoV-2 Demonstrates High Barrier to Resistance
por: Checkmahomed, Liva, et al.
Publicado: (2022)

Scalable live-attenuated SARS-CoV-2 vaccine candidate demonstrates preclinical safety and efficacy
por: Wang, Ying, et al.
Publicado: (2021)

Comparative genomic analysis demonstrates that true reinfection following SARS-CoV-2 infection is possible
por: O Murchu, Eamon, et al.
Publicado: (2021)

Host barriers to SARS-CoV-2 demonstrated by ferrets in a high-exposure domestic setting
por: Sawatzki, Kaitlin, et al.
Publicado: (2021)

Demonstrating the value of medicines: evolution of value equation and stakeholder perception of uncertainties
por: Narayanan, Siva
Publicado: (2016)

Polyhydroxybutyrate production in Bacillus mycoides DFC1 using response surface optimization for physico-chemical process parameters
por: Narayanan, Aarthi, et al.
Publicado: (2012)

Cooperativity between the 3’ untranslated region microRNA binding sites is critical for the virulence of eastern equine encephalitis virus
por: Trobaugh, Derek W., et al.
Publicado: (2019)

Tissue-engineered anterior segment eye cultures demonstrate hallmarks of conventional organ culture
por: Waxman, Susannah, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6q90hhafg3ebjhf3cprgmedpd1